Intelligent Bio Solutions stockholders approve reverse stock split, warrant share issuance, and incentive plan expansion

INTELLIGENT BIO SOLUTIONS INC.

Elected four directors: Boyages, Hurd, Isenberg, Fraser. Boyages received 1,349,921 for, 503,182 withheld.
Approved amendment to 2019 Long Term Incentive Plan, increasing authorized shares from 1.3M to 1.795M (495,000 new shares).
Approved issuance of up to 4,147,616 shares upon warrant exercise (over 20% of outstanding common stock).
Approved reverse stock split at ratio of 1-for-2 to 1-for-10 within 12 months, at Board's discretion, to regain Nasdaq bid price compliance.
Ratified UHY LLP as independent auditor for fiscal year ending June 30, 2026 (4,246,183 for, 227,964 against).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.